Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Investigational Plan:
1. Screening Visit \[Visit 0 / 0-14 days prior to receipt of study drug\]
2. Baseline Visit \[Visit 1 / Provision of study drug and subject training\]
3. Treatment Visit \[Visit 2 / within 72 hours after study drug administration\]
4. Follow-up Visit \[Visit 3 / Telephone follow-up 7-10 days after study drug administration\]
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Adults 18 to 60 years of age
2. Prior effective use of injectable sumatriptan on at least two occasions within the last two months
3. At least two migraines per month suitable injectable sumatriptan
4. Capable of using a migraine self-injection auto-injector
5. Capable of distinguishing between migraine and other headache types (e.g., tension-type headache)
You may not be if
1. Seizure disorders
2. Coronary artery disease (CAD)
3. Cardiac dysrhythmia or pacemaker
4. High blood pressure
5. Liver disease
6. Kidney disease
7. Autoimmune disease
8. History of alcohol or substance abuse
9. Currently pregnant
10. Use of any other investigational drug product within 30 days prior to treatment visit
Clareo Health | A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack
